147 related articles for article (PubMed ID: 22016468)
21. Oncogenic role of long noncoding RNA AF118081 in anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide-transformed 16HBE cells.
Yang Q; Zhang S; Liu H; Wu J; Xu E; Peng B; Jiang Y
Toxicol Lett; 2014 Sep; 229(3):430-9. PubMed ID: 25050996
[TBL] [Abstract][Full Text] [Related]
22. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
[TBL] [Abstract][Full Text] [Related]
23. In vitro malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene.
Zhao P; Fu J; Yao B; Song Y; Mi L; Li Z; Shang L; Hao W; Zhou Z
Toxicol In Vitro; 2012 Mar; 26(2):362-8. PubMed ID: 22227536
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
26. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
[TBL] [Abstract][Full Text] [Related]
27. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
28. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
Pekow J; Meckel K; Dougherty U; Butun F; Mustafi R; Lim J; Crofton C; Chen X; Joseph L; Bissonnette M
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(3):G179-87. PubMed ID: 25477374
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
Wang YY; Ren T; Cai YY; He XY
Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol and prostate cancer: promising role for microRNAs.
Dhar S; Hicks C; Levenson AS
Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
[TBL] [Abstract][Full Text] [Related]
32. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.
García-Cruz R; Camats M; Calin GA; Liu CG; Volinia S; Taccioli C; Croce CM; Bach-Elias M
BMC Med Genet; 2015 Jul; 16():46. PubMed ID: 26138095
[TBL] [Abstract][Full Text] [Related]
33. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
[TBL] [Abstract][Full Text] [Related]
34. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
Lang Q; Ling C
Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).
Sun D; Yu F; Ma Y; Zhao R; Chen X; Zhu J; Zhang CY; Chen J; Zhang J
J Biol Chem; 2013 Mar; 288(13):9508-18. PubMed ID: 23322774
[TBL] [Abstract][Full Text] [Related]
36. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
Frezzetti D; De Menna M; Zoppoli P; Guerra C; Ferraro A; Bello AM; De Luca P; Calabrese C; Fusco A; Ceccarelli M; Zollo M; Barbacid M; Di Lauro R; De Vita G
Oncogene; 2011 Jan; 30(3):275-86. PubMed ID: 20956945
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
39. Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells.
Mollerup S; Ovrebø S; Haugen A
Int J Cancer; 2001 Apr; 92(1):18-25. PubMed ID: 11279601
[TBL] [Abstract][Full Text] [Related]
40. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]